AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion
AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion
AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion
Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance.